3 Winning Evergreen Stocks to Buy and Hold for the Next 25 Years

Vertex Pharmaceuticals (NASDAQ: VRTX) is an evergreen stock because it has proven that it's an expert at consistently extracting wild growth from a tiny niche. Of the 83,000 estimated patients living with the rare hereditary disease cystic fibrosis (CF) in the Western World, Vertex treats more than half of them with its portfolio of drugs, and it's doing a significant amount of research and development work to treat everyone that's left. What's more, Vertex is starting to diversify into developing therapies for other illnesses, ranging from type 1 diabetes to pain and Duchenne muscular dystrophy.